Hussman Strategic Advisors Inc. Reduces Position in Colgate-Palmolive Company $CL

Hussman Strategic Advisors Inc. lowered its holdings in Colgate-Palmolive Company (NYSE:CL) by 20.0% in the third quarter, HoldingsChannel reports. The firm owned 42,000 shares of the company’s stock after selling 10,500 shares during the period. Colgate-Palmolive comprises about 0.7% of Hussman Strategic Advisors Inc.’s portfolio, making the stock its 19th largest holding. Hussman Strategic Advisors Inc.’s holdings in Colgate-Palmolive were worth $3,357,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of CL. Westside Investment Management Inc. grew its position in shares of Colgate-Palmolive by 85.5% during the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after buying an additional 130 shares in the last quarter. Vermillion & White Wealth Management Group LLC boosted its stake in Colgate-Palmolive by 86.1% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock valued at $30,000 after acquiring an additional 155 shares during the last quarter. Copia Wealth Management acquired a new position in Colgate-Palmolive during the 3rd quarter worth $29,000. MTM Investment Management LLC bought a new stake in shares of Colgate-Palmolive in the 2nd quarter worth about $39,000. Finally, Twin Peaks Wealth Advisors LLC acquired a new stake in shares of Colgate-Palmolive in the 2nd quarter valued at about $44,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Price Performance

Shares of CL opened at $85.86 on Wednesday. The company has a debt-to-equity ratio of 5.90, a current ratio of 0.93 and a quick ratio of 0.60. The company has a market cap of $69.21 billion, a P/E ratio of 24.05, a PEG ratio of 5.75 and a beta of 0.30. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $100.18. The stock has a fifty day moving average price of $80.32 and a 200 day moving average price of $81.37.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, October 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.89 by $0.02. Colgate-Palmolive had a net margin of 14.47% and a return on equity of 333.39%. The business had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.17 billion. During the same quarter in the prior year, the firm earned $0.91 earnings per share. The company’s quarterly revenue was up 1.9% on a year-over-year basis. On average, research analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st will be paid a $0.52 dividend. The ex-dividend date is Wednesday, January 21st. This represents a $2.08 annualized dividend and a dividend yield of 2.4%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.26%.

Wall Street Analysts Forecast Growth

CL has been the subject of a number of research reports. Evercore ISI decreased their price target on Colgate-Palmolive from $100.00 to $94.00 and set an “outperform” rating for the company in a research note on Monday, November 3rd. Deutsche Bank Aktiengesellschaft set a $86.00 target price on Colgate-Palmolive in a research report on Friday, October 10th. The Goldman Sachs Group dropped their price target on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a research report on Thursday, October 2nd. Barclays set a $83.00 price objective on shares of Colgate-Palmolive in a report on Friday, January 16th. Finally, Raymond James Financial dropped their target price on shares of Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a report on Monday, October 20th. Eleven equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $89.44.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.